Prelude Capital Management’s Zymergen Inc. Common Stock ZY Stock Holding History

Prelude Capital Management’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-361,939	Closed	-$1.01M	–	1922
2022 Q3	$1.01M	Buy	+361,939	New	+$879K	0.04%	420
2022 Q2	–	Sell	-42,648	Closed	-$123K	–	2223
2022 Q1	$123K	Buy	+42,648	New	+$181K	﹤0.01%	1371

Prelude Capital Management's ZY Position: Q4 2022 in Review

Prelude Capital Management sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 361,939 shares — an estimated $1.01M sold.

Prelude Capital Management first reported a position in ZY in Q1 2022 and held it in 2 quarters. The position peaked at $1.01M in Q3 2022. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Prelude Capital Management reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 361,939 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $1.01M.
Prelude Capital Management first reported a position in Zymergen Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Prelude Capital Management's Zymergen Inc. Common Stock position peaked at $1.01M in Q3 2022.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.